One of the most popular college majors saw some of the highest growing rates of depression, according to a recent survey from ...

UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

Slow-moving Tropical Depression Sara unleashed major rainfall over Honduras this weekend, causing at least one death while ...

A study found that medical students saw the highest rates of increasing depression from 2019 to 2024, at a whopping 35.3 percent.

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

Emerging research suggests that chronic inflammation, rather than neurotransmitter deficiencies alone, may be a major factor ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revoluti ...